Why Is CRISPR Therapeutics (CRSP) Up 3.3% Since Last Earnings Report?

CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Does CRISPR Therapeutics Around 57 Dollars Reflect Its DCF Value After Recent Rally?

If you have been wondering whether CRISPR Therapeutics at around $57 a share is a bargain or a bubble, you are not alone. This stock sits at the crossroads of high science and high expectations. The ...

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.
Zacks Investment Research on MSN

CRISPR Therapeutics AG (CRSP) is attracting investor attention: Here is what you should know

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
TipRanks on MSN

CRISPR Therapeutics AG: Stock surge amid challenges

Crispr Therapeutics AG ( ($CRSP) ) has risen by 9.03%. Read on to learn why. Crispr Therapeutics AG has seen its stock price rise by 9.03% over ...